GlassScriptPhysician profile
Ron D Gottlieb
NPI 1255425849
$1,981.36
in general payments reported to CMS, 2019-2025
20 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $203 · 2021: $12.44 · 2022: $189 · 2023: $294 · 2024: $465 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $284.92 | 2022-2025 | |
| Glaxosmithkline, LLC. | $283.19 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $265.70 | 2019-2025 | Dupixent |
| Genzyme Corporation | $229.63 | 2019-2025 | |
| Kaleo, INC. | $179.41 | 2019-2024 | Auvi-Q |
| Hikma Pharmaceuticals USA | $102.60 | 2022-2025 | Ryaltris |
| Inspire Medical Systems, INC. | $98.70 | 2024-2025 | Inspire |
| Stryker Corporation | $96.72 | 2019 | |
| Medtronic USA, INC. | $90.90 | 2019-2020 | |
| Davol INC. | $89.20 | 2020 | |
| Intersect Ent, INC. | $57.89 | 2019 | |
| Checkpoint Surgical, INC | $33.56 | 2025 | Checkpoint Stimulators |
| Integra Lifesciences Corporation | $33.00 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic, INC. | $26.74 | 2024 | Propel |
| Smith+Nephew, INC. | $24.89 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.02 | 2024 | Bridion |
| Genentech USA, INC. | $20.17 | 2025 | Xolair |
| Amgen INC. | $15.46 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $14.06 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Gottlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.